
CKD is growing as a global health problem, but screenings and treatments aren't reaching patients who need them.

Salvatore Viscomi, M.D., is the co-founder and CEO of Carna Health, a global digital health company transforming the prevention and management of cardio-kidney-metabolic (CKM) disease through AI-powered diagnostics, predictive analytics, and large-scale population screening. A physician-entrepreneur, he has over 20 years of patient-facing experience.

CKD is growing as a global health problem, but screenings and treatments aren't reaching patients who need them.